Intravenous rituximab versus oral mycophenolate mofetil in sustaining remission of calcineurin inhibitor dependent steroid resistant nephrotic syndrome: An open label randomized controlled trial

被引：0
|
作者：
Sinha, Aditi [1 ]
Meena, Jitendra [1 ]
Yadav, Menka [1 ]
Hari, Pankaj [1 ]
Bagga, Arvind [1 ]
机构：
[1] All India Inst Med Sci, Pediat, New Delhi, India
来源：
PEDIATRIC NEPHROLOGY | 2024年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1330
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [31] Intravenous Methylprednisolone Versus Oral Prednisolone for West Syndrome: A Randomized Open-Label Trial
    Kapoor, Dipti
    Sharma, Suvasini
    Garg, Divyani
    Samaddar, Sukla
    Panda, Isha
    Patra, Bijoy
    Mukherjee, Sharmila B.
    Pemde, Harish K.
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (08): : 778 - 784
  • [32] Intravenous Methylprednisolone Versus Oral Prednisolone for West Syndrome: A Randomized Open-Label Trial
    Dipti Kapoor
    Suvasini Sharma
    Divyani Garg
    Sukla Samaddar
    Isha Panda
    Bijoy Patra
    Sharmila B Mukherjee
    Harish K. Pemde
    Indian Journal of Pediatrics, 2021, 88 : 778 - 784
  • [33] EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL WITH NON-INFERIORITY DESIGN
    Mathew, Georgie
    Sinha, Aditi
    Grewal, Neetu
    Ahmed, Aijaz
    Hari, Pankaj
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2021, 36 (09) : 2922 - 2922
  • [34] Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
    Choudhry, Swati
    Bagga, Arvind
    Hari, Pankaj
    Sharma, Sonika
    Kalaivani, Mani
    Dinda, Amit
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (05) : 760 - 769
  • [35] Protocol Of An Open, Randomized, Controlled, Multicenter Trial On The Initial Treatment Of Idiopathic Steroid-sensitive Nephrotic Syndrome In Children With Mycophenolate Mofetil Vs. Prednisone: The Intent Study
    Benz, Marcus R.
    Doetsch, Joerg
    Ehren, Rasmus
    Gellermann, Jutta
    Haffner, Dieter
    Hoyer, Peter F.
    Kemper, Markus J.
    Konrad, Martin
    Querfeld, Uwe
    Toenshoff, Burkhard
    Weber, Lutz T.
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1740 - 1740
  • [36] Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
    Hogan, Julien
    Perez, Aubriana
    Sellier-Leclerc, Anne-Laure
    Vrillon, Isabelle
    Broux, Francoise
    Nobili, Francois
    Harambat, Jerome
    Bessenay, Lucie
    Audard, V
    Faudeux, Camille
    Morin, Denis
    Pietrement, Christine
    Tellier, Stephanie
    Djeddi, Djamal
    Eckart, Philippe
    Lahoche, Annie
    Roussey-Kesler, G.
    Ulinski, Tim
    Boyer, Olivia
    Plaisier, Emmanuelle
    Cloarec, Sylvie
    Jolivot, Anne
    Guigonis, Vincent
    Guilmin-Crepon, Sophie
    Baudouin, Veronique
    Dossier, Claire
    Deschenes, Georges
    BMJ OPEN, 2020, 10 (09):
  • [37] Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
    Ehren, Rasmus
    Benz, Marcus R.
    Doetsch, Jorg
    Fichtner, Alexander
    Gellermann, Jutta
    Haffner, Dieter
    Hocker, Britta
    Hoyer, Peter F.
    Kaestner, Baerbel
    Kemper, Markus J.
    Konrad, Martin
    Luntz, Steffen
    Querfeld, Uwe
    Sander, Anja
    Toenshoff, Burkhard
    Weber, Lutz T.
    BMJ OPEN, 2018, 8 (10):
  • [38] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
    Tomoko Horinouchi
    Mayumi Sako
    Koichi Nakanishi
    Kenji Ishikura
    Shuichi Ito
    Hidefumi Nakamura
    Mari Saito Oba
    Kandai Nozu
    Kazumoto Iijima
    BMC Nephrology, 19
  • [39] Efficacy And Safety Of Oral Tolvaptan Versus Intravenous Furosemide In Childhood Nephrotic Syndrome With Edema - An Open Labelled Randomised Controlled Trial
    Gupta, Aarchie
    Tiewsoh, Karalanglin
    Dawman, Lesa
    Singh, Thakurvir
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S239 - S240
  • [40] CYCLOSPORINE VERSUS CYCLOPHOSPHAMIDE FOR PATIENTS WITH STEROID-DEPENDENT AND FREQUENTLY RELAPSING IDIOPATHIC NEPHROTIC SYNDROME - A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    PONTICELLI, C
    EDEFONTI, A
    GHIO, L
    RIZZONI, G
    RINALDI, S
    GUSMANO, R
    LAMA, G
    ZACCHELLO, G
    CONFALONIERI, R
    ALTIERI, P
    BETTINELLI, A
    MASCHIO, G
    CINOTTI, GA
    FUIANO, G
    SCHENA, FP
    CASTELLANI, A
    DELLACASAALBERIGHI, O
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (12) : 1326 - 1332
12345